Login / Signup

Evaluation of clinical efficacy and laboratory indicators of non-cultured epidermal cell suspension and hair follicle cell suspension in surgical management of stable vitiligo: A randomized comparative trial.

Apoorva ChallaSuman ChauhanRashi PangtiSudheer Kumar AravaSapna PrajapatiAnjali PandeySomesh Gupta
Published in: Journal of cosmetic dermatology (2022)
The median cell yield was eight times higher in ECS than in HFCS with a significantly higher percentage of HMB45+ melanocytes in the former group. The median percentage of re-pigmentation in both groups was 90% at the end of 36 weeks. ECS provides faster re-pigmentation; however, both ECS and HFCS have comparable safety and efficacy over a longer duration of follow-up.
Keyphrases
  • single cell
  • cell therapy
  • randomized controlled trial
  • study protocol
  • bone marrow
  • wound healing
  • gestational age